News – Page 826 – Endpoints News

AstraZeneca trumpets the 'momentous' data they found for Tagrisso in an adjuvant setting for NSCLC — but many of ...

5 years ago

Protalix files BLA to compete with Sanofi Genzyme; Rallybio collects another Alexion alum

5 years ago

In for the long vaccine game, Merck buys into patch delivery tech with pandemic potential

5 years ago

Novartis jumps into Covid-19 vaccine hunt, as Big Pharma and big biotech commit to billions of doses

5 years ago

Capitalizing Pablo: The world’s biggest drug royalty buyer is going public. And the low-key CEO divulges a few ...

5 years ago

Denali unveils new way of crossing blood brain barrier as the big neuroscience bet enters its clinical years

5 years ago

Covid-19 roundup: FDA's Stephen Hahn personally helped a doctor set up hydroxychloroquine trial — report

5 years ago

FDA explains impact of Covid-19 on applications, formal meetings

5 years ago

Venrock survey shows growing recognition of coronavirus toll, waning confidence in arrival of vaccines and treatments

5 years ago

Drug developer, Big Pharma commercial exec, now an upstart biotech chief — Fabrice Chouraqui is ready to try ...

5 years ago

Stymied by the pandemic, Immunomedics' new CEO bows out, taking a million bucks plus perks as he heads out the ...

5 years ago

GSK adds to its trove of positive data for multiple myeloma contender as rivals continue to command the spotlight

5 years ago

La Jolla feels the burn of rival malaria approval; With another $10B, Bayer could finally weed out its herbicide ...

5 years ago

GSK's asthma drug Nucala gets speedy review for rare blood disorder

5 years ago

Dupixent clears PhIII trial in new disease as blockbuster looks to expand past Regeneron-Sanofi split

5 years ago

Gilead leases partner rights to TIGIT, PD-1 in a $2B deal with Arcus. Now comes the hard part

5 years ago

For a post-Soliris world, Atlas-backed Q32 Bio outlines $46M next-gen complement play

5 years ago

Sanofi CEO Paul Hudson has $23B burning a hole in his pocket. And here are some hints on how he plans to spend that

5 years ago

Covid-19 roundup: Buoyed by soaring shares, Novavax inks a $167M deal to buy Covid-19 vaccine-making facility; France ...

5 years ago

Bristol Myers Squibb finally gets in the frontline NSCLC game dominated by Merck, adding a second Opdivo/Yervoy-based ...

5 years ago

In latest cancer deal, Bristol Myers Squibb's new BD chief bets $65M in search for more targets like PARP

5 years ago

AbCellera raises $105M in first major venture round as Covid-19 antibody nears clinic

5 years ago

Ex-biotech chief pleads guilty in college admissions scandal, faces a 10-month prison stretch in plea deal

5 years ago

Biotech Voices: Coronavirus will change biotech research with remote collaborations

5 years ago

First page Previous page 823 824 825826827 828 829 Next page Last page